
Endless Health
A biomarker coaching program for heart & metabolic health.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
* | $4.5m | Seed | |
Total Funding | 000k |
USD | 2023 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Endless Health operates as a preventative medicine and health support company, focusing on cardiovascular and metabolic health for the working-age population. The company was founded in 2022 by Cooper Galvin, who serves as CEO, and Jiabao Li, the Chief Design Officer. The inspiration for the company came from a personal health crisis experienced by Li's mother, which highlighted the need for accessible preventive care. Galvin holds a PhD from Stanford Medicine and previously worked as a consultant for McKinsey, while Li, a Harvard graduate and former Apple designer, has a background in consumer diagnostics.
The firm's business model is multi-faceted, serving individual consumers directly (D2C) and partnering with corporations to offer services as an employee benefit (B2B). Additionally, Endless Health provides white-label testing services and is developing at-home clinical trial contracting services for life sciences research. Revenue is generated through the sale of its health programs and services. The core offering is a comprehensive, full-loop system that begins with in-home testing kits for a wide range of blood biomarkers predictive of long-term cardiovascular and metabolic health, such as Apo-B and Lp(a). Following the tests, clients receive personalized guidance from either AI-driven platforms or live health coaches to implement lifestyle changes. The platform facilitates progress tracking, and subsequent re-testing is conducted to measure the impact of these changes, thereby closing the feedback loop.
In July 2024, the Austin, TX-based company announced it had raised $4.5 million in a seed funding round led by Next Coast Ventures and Asset Management Ventures, with participation from Antler Elevate. This capital is intended to support the expansion of its testing panels to include markers for conditions like Alzheimer's disease, scale its at-home clinical trial services, and enhance its technological infrastructure to serve a larger user base. The company's services include self-collection kits, central lab services, and tools for wellness practitioners to manage their practices, from client intake to results interpretation.
Keywords: preventive medicine, cardiovascular health, metabolic health, at-home blood testing, health coaching, direct-to-consumer healthcare, corporate wellness, clinical trial services, longevity, biomarker tracking, personalized health, digital health, Cooper Galvin, Jiabao Li, Next Coast Ventures, chronic disease prevention, Apo-B testing, health technology, employee benefits, life sciences research